AAAAAA
Results:
1-14
|
Results: 14
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
Authors:
Brada, M
Hoang-Xuan, K
Rampling, R
Dietrich, PY
Dirix, LY
Macdonald, D
Heimans, JJ
Zonnenberg, BA
Bravo-Marques, JM
Henriksson, R
Stupp, R
Yue, N
Bruner, J
Dugan, M
Rao, S
Zaknoen, S
Citation: M. Brada et al., Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse, ANN ONCOL, 12(2), 2001, pp. 259-266
Authors:
Soussain, C
Suzan, F
Hoang-Xuan, K
Cassoux, N
Levy, V
Azar, N
Belanger, C
Achour, E
Ribrag, V
Gerber, S
Delattre, JY
Leblond, V
Citation: C. Soussain et al., Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma, J CL ONCOL, 19(3), 2001, pp. 742-749
Authors:
Leslie, NR
Bennett, D
Gray, A
Pass, I
Hoang-Xuan, K
Downes, CP
Citation: Nr. Leslie et al., Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions, BIOCHEM J, 357, 2001, pp. 427-435
Authors:
Hoang-Xuan, K
He, J
Huguet, S
Mokhtari, K
Marie, Y
Kujas, M
Leuraud, P
Capelle, L
Delattre, JY
Poirier, J
Broet, P
Sanson, M
Citation: K. Hoang-xuan et al., Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression, NEUROLOGY, 57(7), 2001, pp. 1278-1281
Authors:
He, J
Mokhtari, K
Sanson, M
Marie, Y
Kujas, M
Huguet, S
Leuraud, P
Capelle, L
Delattre, JY
Poirier, J
Hoang-Xuan, K
Citation: J. He et al., Glioblastomas with an oligodendroglial component: A pathological and molecular study, J NE EXP NE, 60(9), 2001, pp. 863-871
Authors:
Sanson, M
Napolitano, M
Yaya, R
Keime-Guibert, F
Broet, P
Hoang-Xuan, K
Delattre, JY
Citation: M. Sanson et al., Second line chemotherapy with docetaxel in patients with recurrent malignant glioma: a phase II study, J NEURO-ONC, 50(3), 2000, pp. 245-249
Authors:
He, J
Hoang-Xuan, K
Marie, Y
Leuraud, P
Mokhtari, K
Kujas, M
Delattre, JY
Sanson, M
Citation: J. He et al., P18 tumor suppressor gene and progression of oligodendrogliomas to anaplasia, NEUROLOGY, 55(6), 2000, pp. 867-869
Authors:
Hoang-Xuan, K
Sanson, M
Delattre, JY
Citation: K. Hoang-xuan et al., Biology of gliomas: benefits and clinical prospects, M S-MED SCI, 15(10), 1999, pp. 1075-1077
Authors:
Zhou, XP
Sanson, M
Hoang-Xuan, K
Robin, E
Taillandier, L
He, J
Mokhtari, K
Cornu, P
Delattre, LY
Thomas, G
Hamelin, R
Citation: Xp. Zhou et al., Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressorgenes predispose to gliomas, ANN NEUROL, 46(6), 1999, pp. 913-916
Authors:
Sanson, M
Zhou, XP
Brault, JL
Hoang-Xuan, K
Hamelin, R
Citation: M. Sanson et al., A novel germline mutation of the PTEN/MMAC1 gene in a patient with Cowden disease, ACTA ONCOL, 38(7), 1999, pp. 973-975
Authors:
Pradat, PF
Hoang-Xuan, K
Cornu, P
Mokhtari, K
Martin-Duverneuil, N
Poisson, M
Delattre, JY
Citation: Pf. Pradat et al., Treatment of meningeal gliomatosis, J NEURO-ONC, 44(2), 1999, pp. 163-168
Authors:
Hoang-Xuan, K
Delattre, JY
Citation: K. Hoang-xuan et Jy. Delattre, Ongoing protocols for non-AIDS primary central nervous system lymphoma, J NEURO-ONC, 43(3), 1999, pp. 287-291
Authors:
Pierga, JY
Hoang-Xuan, K
Feuvret, L
Simon, JM
Cornu, P
Baillet, F
Mazeron, JJ
Delattre, JY
Citation: Jy. Pierga et al., Treatment of malignant gliomas in the elderly, J NEURO-ONC, 43(2), 1999, pp. 187-193
Authors:
Zhou, XP
Li, YJ
Hoang-Xuan, K
Laurent-Puig, P
Mokhtari, K
Longy, M
Sanson, M
Delattre, JY
Thomas, G
Hamelin, R
Citation: Xp. Zhou et al., Mutational analysis of the PTEN gene in gliomas: Molecular and pathological correlations, INT J CANC, 84(2), 1999, pp. 150-154
Risultati:
1-14
|